University of Verona, in collaboration with the Alessandra Graziottin Foundation ETS – Academic Year 2026–2027
Course Director: Prof. Stefano Uccella
Scientific Director: Prof. Alessandra Graziottin
Module 9 – Menopause and multimodal therapies (hormonal or non-hormonal) following cancer
May 5–7, 2027
A. Graziottin
- Essential Levels of Assistance (LEA) in iatrogenic menopause
- Multimodal therapy after breast cancer: strategies to optimize systemic and sexual health trajectories
- Multimodal therapy after gastric, lung, and bladder cancers based on hormonal receptor profiles
- Hormonal therapies after non-hormone-dependent cancers – Leukemias and lymphomas
- Hormonal therapies after non-hormone-dependent cancers – Non-melanoma skin cancers
- Hormonal therapies after non-hormone-dependent cancers – Colon cancer
- Prevention and treatment of damage caused by pelvic and total-body radiotherapy
- Doctor-patient communication – Optimizing the therapeutic alliance
- Doctor-patient communication – Taking responsibility, lifestyle choices, and personalized therapy
- Hormones, formulations, and routes of administration, with an in-depth look at pharmaceutical and compounded "bioidentical" products
- Evidence-based preventive and therapeutic lifestyle choices
A. Graziottin, S. Garzon, S. Uccella, I. Porcari, G. Adami, R. Scarsini
Twin skills and strong alliances in specialist collaboration. When to refer, to whom, and why
A. Graziottin, S. Garzon, S. Uccella
Master’s program conclusions
Related links
Master's Program